Table 2.
JEV peptides eliciting T cell responses identified in this study
SubjectPeptideSubsetJEV proteinAmino acid locationTypeHLA restrictionHLA class IHLA class II
ABCDR
JE082/2 GKNRAINMLKRGLPRVF CD4 9–25 JE   11:01, 33:01 13:01, 44:02   DR12, DR14, DR52 
 VFPLVGVKRVVMSLLDGR CD4 24–41         
JE093/2 MLKRGLPRVFPLVGVKRVVMSLLDGR CD4 16–41 JE   24:02, 24:02 13:01, 27:02   DR15, DR51 
JE043/2 SLVNKKEAWLDSTKATRY CD8 230–247 JE   01:01, 11:01 52:01, 57:01   DR3, DR15, DR52, DR51 
 WIIRNPGYAFLAAVLGWM CD4 254–271         
JE101/2 RYLMKTENWIIRNPGYAF CD4 246–263 JE   30:01, 33:01 13:01, 44:02   DR7, DR53 
JE017/2 AKFSCTSKAIGRTIQ CD4 411–425 JE   03:01, 11:02 07:02, 35:01   DR4, DR11, DR52, DR53 
 KQSVVALGSQEGGLHQAL CD4 543–560         
 CRLKMDKLALKGTTYGMCTEKFSF CD4 581–604         
 HGTVVIELSYSGSDGPCK CD4 613–630         
 LGKAFSTTLKGAQRLAAL CD4 697–714         
 WDFGSIGGVFNSIGKAVHQVFGGAF CD4 719–735         
 GVLVFLATNVHADTGCAI CD4 783–801         
H021/1 PWTSPSSTAWRNRELLM CD4 518–534   02:01, 11:01 07:02, 52:01   DR15, DR51 
JE003/2 KYLPETPRSLAKIVHK CD4 + CD8 NS1 827–842 JE   03:01, 33:01 15:01, 37:01   DR10, DR15, DR51 
 AVHSDLSYWIESRYNDTWKLERAVF CD4 NS1 987–1011         
 WIESRYNDTWKLERAVFGEVKSCTW CD4 NS1 995–1019         
JE001/2 EAWVDRYKYLPETPRSLAKIVHK CD4 NS1 820–842 JE   11:01, 31:01 35:01, 52:21   DR4, DR15, DR53, DR51 
 TYALNTFTNIAVQLVRLM CD8 NS5 3136–3153         
H014/3 TAVLAPTRVVAAEMAEAL CD8 NS3 1723–1740   03:01, 30:01 07:02, 13:01 06:02, 07:01   
H001/1 ALRGLPVRY CD8 NS3 1739–1747   11:01, 32:01 15:01, 55:01 01:02, 04:01   
H001/4 DVMCHATL CD8 NS3 1763–1770 B*08:01  01:01, 03:01 08:01, 44:02 05:01, 07:01  DR8, DR17, DR52 
H019/1 NLFVMDEAHFTDPASI CD8 NS3 1784–1799   02:01 38:01, 40:06 07:01, 15:02   
 EAHFTDPASIAARGYI CD8 NS3 1790–1805         
H013/3 NLFVMDEAHFTDPASI CD4 NS3 1784–1799   02:01, 24:02 35:03, 40:06 02:21, 15:02   
 EAHFTDPASIAARGYI CD4 + CD8 NS3 1790–1805         
 GEAAAIFMT CD8 NS3 1812–1820         
JE098/2 ELGEAAAIFMTATPP CD8 NS3 1810–1824 JE   02:01 35:01, 40:06 04:01, 07:01   
H005/1 GCGRGGWSYYAATLKKV CD8 NS5 2608–2624   02:01, 30:01 13:01, 38:01 06:02, 12:02   
 RGYTKGGAGHEEPMLM CD8 NS5 2628–2643         
H010/4 LMQSYGWNL CD8 NS5 2642–2650   01:01, 02:01 08:01, 35:01 04:01, 07:01   
 LVSLKSGVDVFYKPS CD8 NS5 2650–2664         
 YMPKVIEKMEV CD8 NS5 2714–2724         
 NMTSQVLLGRMDRTVWR CD8 NS5 2761–2777         
 HPYRTWTY CD8 NS5 2827–2834  B*35:01       
 TPFGQQRVF CD4 + CD8 NS5 2873–2884         
JE080/2 KLNAMSREEFFKYRREAIIEVDR CD4 NS5 2542–2564 JE   02:01, 33:01 15:05, 44:02   DR7, DR53 
 TWHKDPEHPYRTWTYHGSYEVK CD4 NS5 2820–2841         
H007/2 TMAMTDTTPFGQQRVFK CD4 + CD8 NS5 2869–2885   01:01, 68:01 57:01   DR53, DR7 
H011/3 TMAMTDTTPFGQQRVFK CD8 NS5 2869–2885   02:01, 68:01 37:01, 51:01 06:02, 15:02   
H007/3 TMAMTDTTPFGQQRVFK CD4 + CD8 NS5 2869–2885   11:01, 68:01 07:02, 52:02 07:01, 12:02   
 CTKEEFIKKVNSNAAL CD8 NS5 2923–2938         
 DIAGKQGGKMYADDTAGW CD4 NS5 3050–3067         
H002/3 IWFMWLGARY CD8 NS5 3003–3012   01:01, 29:01 07:05, 57:01 06:02, 15:04   
 RYLEFEALGFL CD4 NS5 3011–3021         
JE054/2 AISGDDCVVKPLDDRFATALHFL CD8 NS5 3191–3213 JE   11:01, 24:02 15:25, 51:01 07:01, 16:01   
JE074/2 CVVKPLDDRFATALHFL CD8 NS5 3197–3213 JE        
H008/4 MTTEDMLQVW CD4 + CD8 NS5 3336–3345 B*58:01  01:01, 33:03 58:01, 15:17 07:01, 03:04  DR13, DR15, DR51, DR52 
 CSAVPVDW CD8 NS5 3312–3319  B*58:01       
JE446/2 GEWMTTEDMLQVWNRVWI CD4 NS5 3333–3350 JE   01:01, 33:01 52:01, 58:01   DR14, DR15, DR52, DR51 
 MLQVWNRVWIEENEWMM CD8 NS5 3341–3357         
SubjectPeptideSubsetJEV proteinAmino acid locationTypeHLA restrictionHLA class IHLA class II
ABCDR
JE082/2 GKNRAINMLKRGLPRVF CD4 9–25 JE   11:01, 33:01 13:01, 44:02   DR12, DR14, DR52 
 VFPLVGVKRVVMSLLDGR CD4 24–41         
JE093/2 MLKRGLPRVFPLVGVKRVVMSLLDGR CD4 16–41 JE   24:02, 24:02 13:01, 27:02   DR15, DR51 
JE043/2 SLVNKKEAWLDSTKATRY CD8 230–247 JE   01:01, 11:01 52:01, 57:01   DR3, DR15, DR52, DR51 
 WIIRNPGYAFLAAVLGWM CD4 254–271         
JE101/2 RYLMKTENWIIRNPGYAF CD4 246–263 JE   30:01, 33:01 13:01, 44:02   DR7, DR53 
JE017/2 AKFSCTSKAIGRTIQ CD4 411–425 JE   03:01, 11:02 07:02, 35:01   DR4, DR11, DR52, DR53 
 KQSVVALGSQEGGLHQAL CD4 543–560         
 CRLKMDKLALKGTTYGMCTEKFSF CD4 581–604         
 HGTVVIELSYSGSDGPCK CD4 613–630         
 LGKAFSTTLKGAQRLAAL CD4 697–714         
 WDFGSIGGVFNSIGKAVHQVFGGAF CD4 719–735         
 GVLVFLATNVHADTGCAI CD4 783–801         
H021/1 PWTSPSSTAWRNRELLM CD4 518–534   02:01, 11:01 07:02, 52:01   DR15, DR51 
JE003/2 KYLPETPRSLAKIVHK CD4 + CD8 NS1 827–842 JE   03:01, 33:01 15:01, 37:01   DR10, DR15, DR51 
 AVHSDLSYWIESRYNDTWKLERAVF CD4 NS1 987–1011         
 WIESRYNDTWKLERAVFGEVKSCTW CD4 NS1 995–1019         
JE001/2 EAWVDRYKYLPETPRSLAKIVHK CD4 NS1 820–842 JE   11:01, 31:01 35:01, 52:21   DR4, DR15, DR53, DR51 
 TYALNTFTNIAVQLVRLM CD8 NS5 3136–3153         
H014/3 TAVLAPTRVVAAEMAEAL CD8 NS3 1723–1740   03:01, 30:01 07:02, 13:01 06:02, 07:01   
H001/1 ALRGLPVRY CD8 NS3 1739–1747   11:01, 32:01 15:01, 55:01 01:02, 04:01   
H001/4 DVMCHATL CD8 NS3 1763–1770 B*08:01  01:01, 03:01 08:01, 44:02 05:01, 07:01  DR8, DR17, DR52 
H019/1 NLFVMDEAHFTDPASI CD8 NS3 1784–1799   02:01 38:01, 40:06 07:01, 15:02   
 EAHFTDPASIAARGYI CD8 NS3 1790–1805         
H013/3 NLFVMDEAHFTDPASI CD4 NS3 1784–1799   02:01, 24:02 35:03, 40:06 02:21, 15:02   
 EAHFTDPASIAARGYI CD4 + CD8 NS3 1790–1805         
 GEAAAIFMT CD8 NS3 1812–1820         
JE098/2 ELGEAAAIFMTATPP CD8 NS3 1810–1824 JE   02:01 35:01, 40:06 04:01, 07:01   
H005/1 GCGRGGWSYYAATLKKV CD8 NS5 2608–2624   02:01, 30:01 13:01, 38:01 06:02, 12:02   
 RGYTKGGAGHEEPMLM CD8 NS5 2628–2643         
H010/4 LMQSYGWNL CD8 NS5 2642–2650   01:01, 02:01 08:01, 35:01 04:01, 07:01   
 LVSLKSGVDVFYKPS CD8 NS5 2650–2664         
 YMPKVIEKMEV CD8 NS5 2714–2724         
 NMTSQVLLGRMDRTVWR CD8 NS5 2761–2777         
 HPYRTWTY CD8 NS5 2827–2834  B*35:01       
 TPFGQQRVF CD4 + CD8 NS5 2873–2884         
JE080/2 KLNAMSREEFFKYRREAIIEVDR CD4 NS5 2542–2564 JE   02:01, 33:01 15:05, 44:02   DR7, DR53 
 TWHKDPEHPYRTWTYHGSYEVK CD4 NS5 2820–2841         
H007/2 TMAMTDTTPFGQQRVFK CD4 + CD8 NS5 2869–2885   01:01, 68:01 57:01   DR53, DR7 
H011/3 TMAMTDTTPFGQQRVFK CD8 NS5 2869–2885   02:01, 68:01 37:01, 51:01 06:02, 15:02   
H007/3 TMAMTDTTPFGQQRVFK CD4 + CD8 NS5 2869–2885   11:01, 68:01 07:02, 52:02 07:01, 12:02   
 CTKEEFIKKVNSNAAL CD8 NS5 2923–2938         
 DIAGKQGGKMYADDTAGW CD4 NS5 3050–3067         
H002/3 IWFMWLGARY CD8 NS5 3003–3012   01:01, 29:01 07:05, 57:01 06:02, 15:04   
 RYLEFEALGFL CD4 NS5 3011–3021         
JE054/2 AISGDDCVVKPLDDRFATALHFL CD8 NS5 3191–3213 JE   11:01, 24:02 15:25, 51:01 07:01, 16:01   
JE074/2 CVVKPLDDRFATALHFL CD8 NS5 3197–3213 JE        
H008/4 MTTEDMLQVW CD4 + CD8 NS5 3336–3345 B*58:01  01:01, 33:03 58:01, 15:17 07:01, 03:04  DR13, DR15, DR51, DR52 
 CSAVPVDW CD8 NS5 3312–3319  B*58:01       
JE446/2 GEWMTTEDMLQVWNRVWI CD4 NS5 3333–3350 JE   01:01, 33:01 52:01, 58:01   DR14, DR15, DR52, DR51 
 MLQVWNRVWIEENEWMM CD8 NS5 3341–3357         

JE, recovered JE patient; H, healthy JEV-exposed donor; D, dengue exposed. In total, 57 responses to 40 peptides (or adjacent pairs of peptides) were identified.

or Create an Account

Close Modal
Close Modal